Abstract:Obesity (BMI > 30) and large masses do not contraindicate laparoscopic adrenalectomy. Left adrenalectomies bleed more and have a higher morbidity. Hemostatic device choice is up to surgeon's preference.
“…There are some studies in the literature comparing Ligasure and Ultracision in laparoscopic colectomy 9,12,13 and adrenalectomy 14 . We think that the present study is the first to address this topic in laparoscopic splenectomy.…”
Section: Introductionmentioning
confidence: 76%
“…10,11 There are some studies in the literature comparing Ligasure and Ultracision in laparoscopic colectomy 9,12,13 and adrenalectomy. 14 We think that the present study is the first to address this topic in laparoscopic splenectomy. The aim of the present study was to compare the effectiveness of Ligasure alone or Ligasure and Ultracision together in LS.…”
Section: Introductionmentioning
confidence: 80%
“…However Sartori et al . could not find any difference between LigaSure and Ultracision in laparoscopic adrenalectomy according to operating time, blood loss, complications and conversion rate 14 . They concluded that the choice of the haemostatic device was up to surgeon's preference.…”
Background: More effective energy‐based haemostatic devices, such as LigaSure and Ultracision, have made laparoscopic solid organ surgery, such as laparoscopic splenectomy (LS), feasible and have facilitated its advancement. The aim of the present study was to compare the effectiveness of Ligasure alone or Ligasure and Ultracision together in LS.
Methods: Between February 2007 and August 2010, 25 consecutive adult patients (16 male, 9 female, mean age 35 years) who underwent LS with a wide range of immune trombositopenic purpura (ITP) were studied retrospectively. The patients were evaluated in two groups. The first group of 12 patients was the LigaSure group, and the second group of 13 patients was the LigaSure + Ultracision group. The two groups were compared according to operating time, blood loss and postoperative hospital stay. Groups were well matched according to age, sex, spleen size and weight, body mass index, converting and complication rate.
Results: Mean operative time was significantly shorter for the LigaSure + Ultracision group versus the LigaSure group (112.3 vs 147.5 min; P = 0.002). Mean intraoperative blood loss was slightly lower for the LigaSure + Ultracision group vs the LigaSure group, but it was not statistically significant (122.3 vs 142.5 mL; P = 0.219). There was no significant difference in mean postoperative hospital stay for both groups (2.3 vs 2.9 days; P = 0.093).
Conclusion: LS must be the first choice for removal of the spleen, particularly for benign haematological disorders. One of the most important factors to achieve advanced laparoscopic surgery, such as LS, is new energy‐based devices, such as LigaSure and Ultracision. Using LigaSure and Ultracision together in LS reduces the operating time.
“…There are some studies in the literature comparing Ligasure and Ultracision in laparoscopic colectomy 9,12,13 and adrenalectomy 14 . We think that the present study is the first to address this topic in laparoscopic splenectomy.…”
Section: Introductionmentioning
confidence: 76%
“…10,11 There are some studies in the literature comparing Ligasure and Ultracision in laparoscopic colectomy 9,12,13 and adrenalectomy. 14 We think that the present study is the first to address this topic in laparoscopic splenectomy. The aim of the present study was to compare the effectiveness of Ligasure alone or Ligasure and Ultracision together in LS.…”
Section: Introductionmentioning
confidence: 80%
“…However Sartori et al . could not find any difference between LigaSure and Ultracision in laparoscopic adrenalectomy according to operating time, blood loss, complications and conversion rate 14 . They concluded that the choice of the haemostatic device was up to surgeon's preference.…”
Background: More effective energy‐based haemostatic devices, such as LigaSure and Ultracision, have made laparoscopic solid organ surgery, such as laparoscopic splenectomy (LS), feasible and have facilitated its advancement. The aim of the present study was to compare the effectiveness of Ligasure alone or Ligasure and Ultracision together in LS.
Methods: Between February 2007 and August 2010, 25 consecutive adult patients (16 male, 9 female, mean age 35 years) who underwent LS with a wide range of immune trombositopenic purpura (ITP) were studied retrospectively. The patients were evaluated in two groups. The first group of 12 patients was the LigaSure group, and the second group of 13 patients was the LigaSure + Ultracision group. The two groups were compared according to operating time, blood loss and postoperative hospital stay. Groups were well matched according to age, sex, spleen size and weight, body mass index, converting and complication rate.
Results: Mean operative time was significantly shorter for the LigaSure + Ultracision group versus the LigaSure group (112.3 vs 147.5 min; P = 0.002). Mean intraoperative blood loss was slightly lower for the LigaSure + Ultracision group vs the LigaSure group, but it was not statistically significant (122.3 vs 142.5 mL; P = 0.219). There was no significant difference in mean postoperative hospital stay for both groups (2.3 vs 2.9 days; P = 0.093).
Conclusion: LS must be the first choice for removal of the spleen, particularly for benign haematological disorders. One of the most important factors to achieve advanced laparoscopic surgery, such as LS, is new energy‐based devices, such as LigaSure and Ultracision. Using LigaSure and Ultracision together in LS reduces the operating time.
“…The most recent article published about new hemostatic devices in laparoscopic adrenalectomy was conducted in 2010 by Sartori et al 6 They reported their experience of 46 patients undergoing laparoscopic adrenalectomy with EBVS or US: the authors failed to demonstrate any differences in the outcomes between the two groups and concluded that hemostatic device choice is up to surgeon's preference. 6 …”
Section: Discussionmentioning
confidence: 99%
“…Nevertheless, in the present study, the operative time in US group was comparable with those reported in the literature. 6 Valeri et al 4 reported a significantly reduced operative time with the use of US, but this might be due to their rare use of hemostatic clips for the adrenal vein.…”
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.